Management of patients with ovarian cancer in the COVID-19 era.
Giorgio BoganiJvan CasarinCiro PinelliViolante Di DonatoSara BosioSimona RuisiClaudia BrusadelliRocco GuerrisiGiuseppe SarpietroAntonino DittoFabio GhezziFrancesco RaspagliesiPublished in: Journal of surgical oncology (2020)
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.